BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34087856)

  • 1. Correlation of microRNA-367 in the clinicopathologic features and prognosis of breast cancer patients.
    Liu B; Pan J; Fu C
    Medicine (Baltimore); 2021 Jun; 100(22):e26103. PubMed ID: 34087856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
    Qiao EQ; Yang HJ; Zhang XP
    J Zhejiang Univ Sci B; 2020 Jun; 21(6):495-508. PubMed ID: 32478495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis.
    Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R
    Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-302b is associated with poor prognosis and tumor progression of breast cancer.
    Ma J; Zhou Z
    Breast Cancer; 2020 Mar; 27(2):291-298. PubMed ID: 31721061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of miR-597 is correlated with tumor stage and poor outcome in breast cancer.
    Zhang XY; Liu DJ; Yuan RB; Zhang DH; Li SR; Zhang SH; Zhang LY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):456-460. PubMed ID: 29424903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of microRNA-497 and its prognostic significance in human breast cancer.
    Wang S; Li H; Wang J; Wang D
    Diagn Pathol; 2013 Oct; 8():172. PubMed ID: 24143964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
    RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer.
    Kalinina T; Kononchuk V; Alekseenok E; Obukhova D; Sidorov S; Strunkin D; Gulyaeva L
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33923732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
    Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
    Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival.
    Meshkat M; Tanha HM; Naeini MM; Ghaedi K; Sanati MH; Meshkat M; Bagheri F
    Cancer Biomark; 2016 Jul; 17(2):213-22. PubMed ID: 27434289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of miR-1179 inhibits breast cancer cell metastasis by modulating Notch signaling pathway and correlates with favorable prognosis.
    Li WJ; Xie XX; Bai J; Wang C; Zhao L; Jiang DQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8374-8382. PubMed ID: 30556878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
    Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
    Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
    Wang S; Li H; Wang J; Wang D; Yao A; Li Q
    Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer.
    Zhang P; Fan C; Du J; Mo X; Zhao Q
    Int J Exp Pathol; 2018 Aug; 99(4):199-205. PubMed ID: 30175411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
    Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival.
    Li Y; Hong F; Yu Z
    J Int Med Res; 2013 Jun; 41(3):596-602. PubMed ID: 23696595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.